100s of titles, one news app for just $10 a month.
Latest Business news:
Travel patterns have changed for good. Transport systems should, too
Enough with all the radii
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
The cryptocurrency sell-off has exposed those swimming naked
And investors are beginning to discriminate
No slump for pump and dump cryptocurrency gangs
Paris (AFP) - In a sleepy corner of the crypto-economy, the value of an obscure coin called Enzyme was tumbling…
ASX slip after rising on tech, US stocks rally on rate rise outlook
Australian shares fall after a positive start on Thursday, following a strong session on Wall Street as investors cling onto…
Apple will finally make deleting your app accounts less of a nightmare
For apps that offer account creation, a new account deletion policy goes into effect at the end of June.
From analysis to good news, read the world’s best news in one place
Pay ‘with a smile or a wave’: Mastercard face recognition system
Mastercard’s “smile to pay” system, announced last week, is supposed to save time for customers at checkouts. It is being…
Power prices to surge up to 18.3 per cent as energy market turmoil flows through to households
Benchmark power prices will rise by up to 18.3 per cent as the energy industry watchdog seeks to pass on…

Evaxion Biotech: Q1 Earnings Insights

By Benzinga Insights

 

Evaxion Biotech (NASDAQ:EVAX) reported its Q1 earnings results on Wednesday, May 11, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.

Earnings

Evaxion Biotech beat estimated earnings by 24.24%, reporting an EPS of $-0.25 versus an estimate of $-0.33.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.1 which was followed by a 1.85% drop in the share price the next day.

 

To track all earnings releases for Evaxion Biotech visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.